DEEPCAUSALAI
Mark Identification

DEEPCAUSALAI

Serial Number

98855929

Filing Date

Nov 15, 2024

Trademark by

PRESCRIPTIVE GENOMICS INC.

Classification Information

Analyzing and compiling business data for making predictions based on data inputs; Business data analysis; Business research and data analysis services in the field of patient treatment managment; Compiling and analyzing statistics, data and other sources of information for business purposes

Advertising and Business

Downloadable computer software for producing financial models; Downloadable computer software using artificial intelligence (AI) for drug discovery and development; Downloadable computer software using artificial intelligence (AI) for therapeutic drug selection and optimization; Downloadable computer software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Downloadable computer software using artificial intelligence (AI) for therapeutic target selection and optimization; Downloadable computer software using artificial intelligence (AI) for drug design; Downloadable computer software using artificial intelligence (AI) for collecting, analyzing and organizing data in the field of deep learning; Downloadable computer software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Downloadable computer software using artificial intelligence (AI) for patient management, treatment, risk assessment and selection of specific interventions

Electrical and Scientific Apparatus

Financial analysis, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial data analysis; Financial risk assessment services; Financial advisory and consultancy services, namely, compiling and analyzing statistics, data and other sources of information for financial purposes; Financial advisory and consultancy services, namely, in the area of healthcare

Insurance and Financial

Computer software design; Developing computer software; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug discovery and development; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for therapeutic drug selection and optimization; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for predicting drug effectiveness, interactions and side effects; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug design; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for generating personal patient treatment plans based on predictive analytics; Software authoring; Software design and development

Computer and Scientific